1-Methyl-5-(trifluoromethyl)pyrazole-4-carboxylic Acid>98.0%(GC)(T)1g

6-Bromo-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrazine, 97%, 250mg

4-Chloro-5,6-diphenylfuro[2,3-d]pyrimidine, 98%, 1g

2-(3,5-Dimethylbenzoyl)-6-methylpyridine, 97.0%, 1g

5-(Chloromethyl)-1-methyl-1H-imidazole Hydrochloride, 95.0%, 100mg

3-Chloro-5-(trifluoromethyl)pyridine-2-carboxylate acid, 97.0%, 25g

Cyclothiazide (mixture of isomers)>95.0%(HPLC)100mg

5-Fluorochroman-4-one, 95.0%, 10g

Filtration unit Rapid-Flow with PES membrane Pore size 0.2 μm, 500 ml, 500 ml, 75 mm, 12 Piece(s)

2,6-Dichloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine, 95.0%, 25g

7-Bromo-3-chloroisoquinoline, 95.0%, 10g

(2E)-1-(3-bromophenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

N-(6-(2,2,2-TRIFLUOROACETAMIDO)HEXYL)ACRYLAMIDE, 95.0%, 1g